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ABSTRACT
Since its inception in 1994, The RNA Modification
Database (RNAMDB, http://rna-mdb.cas.albany.
edu/RNAmods/) has served as a focal point for
information pertaining to naturally occurring RNA
modifications. In its current state, the database
employs an easy-to-use, searchable interface
for obtaining detailed data on the 109 currently
known RNA modifications. Each entry provides the
chemical structure, common name and symbol,
elemental composition and mass, CA registry
numbers and index name, phylogenetic source,
type of RNA species in which it is found, and refer-
ences to the first reported structure determination
and synthesis. Though newly transferred in its
entirety toThe RNAInstitute, theRNAMDB continues
to grow with two notable additions, agmatidine and
8-methyladenosine, appended in the last year. The
RNA Modification Database is staying up-to-date
with significant improvements being prepared for in-
clusion within the next year and the following year.
The expanded future role of The RNA Modification
Database will be to serve as a primary information
portal for researchers across the entire spectrum of
RNA-related research.
INTRODUCTION
The chemical composition of an RNA molecule allows for
its inherent ability to play many roles within biological
systems. This ability is further enhanced through the site
selected addition of the 109 currently known post-
transcriptional modiﬁcations catalyzed by speciﬁc RNA
modiﬁcation enzymes (1). These naturally-occurring modi-
ﬁcations are found in all three major RNA species (tRNA,
mRNA and rRNA) in all three primary phylogenetic
domains (Archaea, Bacteria and Eukarya) as well as in
a handful of other RNA species such as snRNA (2–5)
(Table 1). The modiﬁcations are one of the most evolution-
arily conserved properties of RNAs. Due in large part to
comprehensive investigations into the structural and func-
tional roles of modiﬁed nucleotides in tRNA, signiﬁcant
advancements have been achieved in our understanding
of the various roles played by these modiﬁcations (2,6–9).
The need to provide a comprehensive, searchable database
to house this wealth of knowledge led to the ﬁrst iteration
of The RNA Modiﬁcation Database (RNAMDB) in 1994
(10). The current version of the database, now housed
at The RNA Institute at the University at Albany
SUNY, contains all naturally-occurring, RNA-derived
modiﬁed ribonucleosides for which the chemical structures
are known. The RNAMDB provides a user-friendly,
searchable interface that directs the user to a detailed infor-
mation page for each database entry (Figure 1).
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DATABASE AND CONTENTS
A comprehensive introduction page provides a detailed
overview of the current state of the RNAMDB, an
in-depth description of the entries and a page speciﬁcally
dedicated to modiﬁcations found in ribosomal RNA. The
overview section of the introduction page provides a focus
on commonly used symbols representing RNA modiﬁca-
tions, reasons for exclusion of certain modiﬁed nucleo-
sides and an extensive listing of reviews for further
reference.
Presently, the information page for each RNAMDB
entry contains the following details (Figure 2a–g).
(a) Chemical structure of the modiﬁed nucleoside: this
structure is simplistic and is not meant to imply the
preferred orientation of dihedral angles or sugar
pucker.
(b) Common name and symbol.
(c) The searchable Chemical Abstracts registry numbers
and index name, which may provide stereochemical
information not shown in the chemical structure.
(d) Elemental composition and molecular weight.
(e) Phylogenetic source of the RNA (i.e. Archaea,
Bacteria or Eukarya) and the type of RNA species
in which it is found (i.e. tRNA, rRNA, etc.).
(f) Literature references for the ﬁrst reported structure
and synthesis. Reports of more recent synthesis or
reﬁnements can be found using the Chemical
Abstracts registry numbers noted above.
(g) Comments pertaining to any of the information
provided on the entry information page provided
by database curators.
Figure 1. The user-friendly search page makes it easy for users to ﬁnd RNA modiﬁcations in the database based on a variety of different criteria.
Table 1. The RNA modiﬁcations in the database are present in all
phylogenetic groups and in many of the known RNA species
RNA Phylogenetic source
Archaea Bacteria Eukarya




SSU 11 8 18







Other Small RNA 1
aDenotes rRNA modiﬁcations in which the subunit of origin is either
unknown or reported as a mixture of subunits.
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2-methyladenosine has been provided (Figure 2). The
RNAMDB contains 109 such entries that consist of 93
found in tRNAs, 31 in rRNA, 13 in mRNA and 14 in
other RNA species such as snRNA, snoRNA and
miRNA (3,4,6) (Table 1).
In addition to the Introduction and Search pages, the
website contains a compilation of links to other helpful
databases and search tools, and provides access to a suite
of programs, Masspec Toolbox, designed to assist in the
identiﬁcation and characterization of nucleic acids by
mass spectrometry (MS). These dedicated programs are
capable of calculating the mass of ribo- and deoxyribo-
oligonucleotides from their sequence, as well as predicting
the masses of products obtained by submitting these
molecules to tandem mass spectrometry (MS/MS), or
to digestion by endo- and exonucleases. Other tools
can calculate nucleotide and elemental composition
from a certain mass and provide the corresponding
isotopic distribution. All of these tools allow for users
to account for the presence of chemically modiﬁed nucleo-
tide residues.
RECENT ADDITIONS
Since the publication of the last database overview (3),
14 new entries have been added to the RNAMDB,
including agmatidine and 8-methyladenosine, which have
both been added within the past year (11–25) (Table 2).
Agmatidine (C
+) was recently found in archaeal AUA-
decoding tRNA
Ile2, where it performs a function similar
to lysidine, a modiﬁed cytidine residue containing lysine in
Figure 2. The entry information page for 2-methyladenosine shows a typical representation of the statistics that are contained within the database.
Nucleic Acids Research, 2011,Vol.39, Database issue D197place of the C2-oxo group, in bacteria (23). In Escherichia
coli, the presence of lysidine at the ﬁrst position of the
anticodon allows for AUA-decoding tRNA
Ile2 to recog-
nize A and not G in the third position of the codon (26).
Agmatidine has a structure very similar to lysidine in
which agmatine (decarboxy-arginine) replaces the
C2-oxo group of cytidine (Figure 3a) and, at the ﬁrst
position of the anticodon, performs the same function of
differentiating between A and G at the third position of
the codon in Haloarcula marismortui (23). The discrimin-
ation between A and G that results from the presence
of lysidine or agmatidine is hypothesized to play an im-
portant role in the stabilization of potential positively
charged tautomeric structures at neutral pH, which are
able to selectively base pair with A (23).
Similar to 2-methyladenosine (m
2A) (27),
8-methyladenosine (m
8A, Figure 3b) is present in the
large subunit of bacterial ribosomes, speciﬁcally in the
peptidyl transferase center at position A2503 of 23S
rRNA as conﬁrmed by comparison to the chemically
synthesized mononucleoside (24). Whereas the m
2A chem-
istry shows only a small amount of antibiotic resistance
(28), the m
8A moiety confers extensive resistance to
ﬁve major classes of peptidyl transferase-targeting anti-
biotics (29). Interestingly, the m
8A mononucleoside
was also synthesized in 1993 and shown to be a potent
inhibitor of vaccinia virus (25). This modiﬁcation is a
clear example of why it is important to understand the
purpose of RNA modiﬁcations in living systems and
how they can be utilized for therapeutic purposes. As an
interesting side note, the presence of dimethylated A2503
(m
2m
8A) was also reported (24); however, this modiﬁca-
tion has yet to be fully characterized or structurally
conﬁrmed.
THE RNA INSTITUTE TAKES OVER AS CURATOR
As of January 2009, upkeep and supervision of the
RNAMDB has been turned over to The RNA Institute.
Already, this transfer has resulted in a major layout
makeover in May 2009 to match the theme of the newly
established institute. As a part of its mission, The RNA
Institute will be expected to become a proposed hub of
cutting edge RNA research and a leading provider of struc-
tural and functional information in the ﬁeld of RNA
modiﬁcations. For this reason, The RNA Institute will
provide the logical base for new enhancements aimed at
expanding the focus of the current infrastructure to cover
other important aspects of modern RNA research. These
enhancements will be embodied by the proposed creation
of a portal that will constitute a primary resource for re-
searchers across the entire spectrum of RNA-related dis-
ciplines. The portal will not only include the current
RNAMDB and associated tools, but from this new infra-
structure, users will be able to access other informatics
resources for RNA science, including different repositories
of experimental protocols, force ﬁeld parameters for mo-
lecular dynamics simulations (30), and sister databases
dedicated to non-natural RNA modiﬁcations. The infra-
structure for all of the above-mentioned improvements
will be implemented on a rolling basis as they are
completed during 2011. A full-featured RNA portal is a
goal to be reached in 2012.
The experimental protocols made available by the
RNAMDB portal will comprise established procedures
that are common practices in a typical RNA lab, but
will also include new cutting-edge methods developed by
the broader RNA community. The RNA Institute will be
Table 2. Fourteen modiﬁcations have been added to the database since the last update was published in 1999
Entry Symbol Common name Phylogenetic source RNA type References
96 m
1Gm 1,20-O-dimethylguanosine Archaea tRNA (11,12)
97 m
1Am 1,20-O-dimethyladenosine Eukarya tRNA (13,14)
98 tm
5U 5-taurinomethyluridine Eukarya tRNA (15,16)
99 tm
5s
2U 5-taurinomethyl-2-thiouridine Eukarya tRNA (15,16)
100 imG-14 4-demethylwyosine Archaea tRNA (17,18)
101 imG2 isowyosine Archaea tRNA (17)
102 ac
6A N
6-acetyladenosine Archaea tRNA (19,20)
103 inm
5U 5-(isopentenylaminomethyl)uridine Bacteria tRNA (21)
104 inm
5s
2U 5-(isopentenylaminomethyl)-2-thiouridine Bacteria tRNA (21)
105 inm
5Um 5-(isopentenylaminomethyl)-20-O-methyluridine Bacteria tRNA (21)
106 m
2,7Gm N





4,20-O-trimethylcytidine Archaea tRNA (22)
108 C
+ agmatidine Archaea tRNA (23)
109 m
8A 8-methyladenosine Bacteria rRNA (24,25)
Figure 3. The two most recent additions to The RNA Modiﬁcation
Database: (a) agmatidine and (b) 8-methyladenosine, have been
discovered and structurally characterized within the past year.
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section, due to the research interests of its members and
the nature of their collaborations, which involve the de-
velopment of enabling technologies based on a wide range
of experimental approaches, including nuclear magnetic
resonance, X-ray crystallography, single-molecule spec-
troscopy and, with the recent opening of The RNA
Mass Spectrometry Center, high-resolution mass spec-
trometry. However, any investigator engaged in RNA
research will be encouraged to share his/her favorite tech-
niques with the broader RNA community through the
portal. Any new protocol will require proof, either
through publication in a peer-reviewed journal or empir-
ical representative data that demonstrate its usefulness,
effectiveness and reproducibility. Links to other
repositories of information on speciﬁc methods, such as
peer-reviewed scientiﬁc journals, will allow users to
conveniently access the most up-to-date and well-
characterized methods in the literature. While it is import-
ant to note that this enhancement will take a great deal of
time to populate in the next 2 years with useful protocols
from the various disciplines within the RNA community,
the initial steps for incorporation into the RNAMDB are
currently in progress.
The proposed portal will be hosting a number of
tools for predicting RNA secondary structure folding,
the energy of those structures, and their predicted
biophysical properties, such as melting temperature. For
instance, the popular RNA folding programs Mfold (31)
and UNAfold (32) developed by Dr Michael Zuker
will soon be accessible through the current RNAMDB
infrastructure and will be subsequently incorporated
in the portal. Full integration will be achieved by
making the information stored in the RNAMDB
directly accessible by the folding algorithms in such a
way as to enable users to calculate the possible effects
of RNA modiﬁcations on energetics and structure
stability. Since a drastic restructuring of the source
code will be required, full integration of Dr Zuker’s
folding programs will likely be implemented during
the 2012–13 academic year; however, the programs are
currently included, in their previous state, as a part of
the RNAMDB. In a similar fashion, we plan on modifying
existing software to enable the productive utilization of
the information in the RNAMDB. For example, full inte-
gration with the programs in the existing Masspec
Toolbox suite will greatly beneﬁt the MS identiﬁcation
and characterization of natural RNAs extracted from
living organisms. The new tools developed for the portal
will be designed to take advantage of the information
stored in the site and, thus, will be capable of accessing
the different types of data and seamlessly communicating
with one another across the board.
The proposed portal will include a constantly updated
compilation of hyperlinks to external sources that may
provide additional information for the identiﬁcation and
the structure–function investigation of RNA. In addition
to repositories of experimental protocols, these links
will direct users to pertinent peer-reviewed journals, the
RNA Society, the Transfer RNA Database (33), the
Collaboratory for MS3D (34) and many others. Links
will also smoothly point users to the external primary
sources of information contained in the RNAMDB
website. For instance, users will no longer be required to
copy and paste the Chemical Abstracts registry numbers
from the RNAMDB to the CAS Registry website. Instead,
they will simply need to click on the hyperlinked CAS
Registry number. Similarly, all references to both
internal and external sources will be hyperlinked to
provide quick access to all primary information.
Additionally, it has become apparent that the information
contained within the RNAMDB can be supplemented by
cross-referencing with other relevant information residing
in other databases such as Modomics (1) and tRNAdb (33).
Other planned enhancements to the RNAMDB
functionalities include incorporation and cross-referencing
with new sister databases containing the growing amount
of information on both natural and non-natural RNA
modiﬁcations. A sister database of force ﬁeld parameters
for molecular dynamics simulations will also be included
as a supplement to the newly incorporated table of
modiﬁed nucleoside base pairing free energy (G)
minima (35). Although excluded from the current
RNAMDB, non-natural modiﬁcations are gaining
increasing interest in both academic and corporate
settings. These types of modiﬁcations include those used
as research tools because of their ability to ﬂuoresce (36),
to restrict certain geometries, including backbone alter-
ations (37), to enable unusual base pairing schemes (38)
and to act as tools for probing structure (39,40).
Furthermore, other non-natural nucleosides that have
been discovered as the products of interactions with
pharmaceuticals and as a result of environmental stimuli
will be also included.
Finally, it is becoming apparent that a more modern
user interface will be needed to accommodate these new
enhancements. With recent technological improvements,
such as deep transcriptome analysis (41) and high-
throughput mass spectrometry (42,43), which have led to
advancements in our current understanding of RNA in
biological systems, it has become necessary to create a
more automated method for researchers to submit their
ﬁndings to the RNAMDB for consideration. The new user
interface is being developed for implementation during
2011 and will seek to create a more user-friendly experi-
ence while adding improved functionality. The new
interface will allow the curators to dedicate more of
their time and resources towards validating entries and
developing new features. In this direction, while past iter-
ations allowed for unpublished modiﬁcations to be
included (Table 2), the new implementation and curating
structure will require publication as a criterion for entry
into the RNAMDB. This will create a benchmark for the
inclusion of modiﬁcations that have been diligently
characterized and will reduce the likelihood of inaccurate
entries.
AVAILABILITY
The RNA Modiﬁcation Database is freely available to
researchers via the web address: http://rna-mdb.cas
Nucleic Acids Research, 2011,Vol.39, Database issue D199.albany.edu/RNAmods/. Additionally, the programs con-
tained in the Masspec Toolbox are also free for public use
through the link on the database homepage and via the
web address: http://rna-mdb.cas.albany.edu/RNAmods/
rnamass.htm. Users of information contained within this
database are requested to cite this article as their source of
information.
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